Kavuru Vimal 4
4 · Acasti Pharma Inc. · Filed Sep 30, 2022
Insider Transaction Report
Form 4
Kavuru Vimal
Director
Transactions
- Award
Stock Options (Right to Buy)
2022-09-28+45,000→ 45,000 totalExercise: $0.59Exp: 2032-09-28→ Class A Common Shares (45,000 underlying)
Footnotes (2)
- [F1]Based on conversion of exercise price of C$0.80 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7321 on the date of grant.
- [F2]Stock options granted on 09/28/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.